GHDX - Genomic Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue-340,750327,868287,458
Cost of Revenue121,96861,50362,16563,223
Gross Profit272,143279,247265,703224,235
Operating Expenses
Research Development-52,82656,82144,857
Selling General and Administrative239,716219,095221,714207,270
Non Recurring----
Others----
Total Operating Expenses361,684333,424340,700315,350
Operating Income or Loss32,4277,326-12,832-27,892
Income from Continuing Operations
Total Other Income/Expenses Net-7,656-9,679294-6,412
Earnings Before Interest and Taxes32,4277,326-12,832-27,892
Interest Expense----
Income Before Tax--2,353-12,538-34,304
Income Tax Expense-1,5041,381-996
Minority Interest----
Net Income From Continuing Ops--3,857-13,919-33,308
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--3,857-13,919-33,308
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--3,857-13,919-33,308